Pemvidutide
Definition
An investigational GLP-1 + glucagon dual receptor agonist developed by Altimmune. The dual-mechanism design targets both appetite suppression (GLP-1) and increased energy expenditure (glucagon). Currently in phase 2/3 trials for obesity and MASH. Not FDA-approved.
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
Related terms in drug
Looking for more depth?
- GLP-1 pipeline tracker
- Browse the full GLP-1 glossary (124 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers